A
PTCT icon

AlphaQuest’s PTC Therapeutics PTCT Stock Holding History

AlphaQuest’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,104
Closed -$312K – 1570
2025
Q4 		$312K Sell
4,104
-1,967
-32% -$143K 0.02% 1183
2025
Q3 		$373K Sell
6,071
-1,838
-23% -$95.7K 0.02% 1002
2025
Q2 		$386K Buy
7,909
+6,102
+338% +$290K 0.04% 743
2025
Q1 		$92.1K Buy
1,807
+725
+67% +$36.2K 0.01% 1333
2024
Q4 		$48.8K Sell
1,082
-21,277
-95% -$911K 0.01% 1294
2024
Q3 		$830K Buy
22,359
+18,171
+434% +$608K 0.07% 434
2024
Q2 		$128K Buy
+4,188
New +$136K 0.02% 871

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AlphaQuest's PTCT Position: Q1 2026 in Review

AlphaQuest sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 4,104 shares — an estimated $312K sold.

AlphaQuest first reported a position in PTCT in Q2 2024 and held it in 7 quarters. The position peaked at $830K in Q3 2024. 352 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • AlphaQuest reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 4,104 PTC Therapeutics shares in Q1 2026, an estimated $312K.
  • AlphaQuest first reported a position in PTC Therapeutics in Q2 2024 and held it in 7 quarters.
  • AlphaQuest's PTC Therapeutics position peaked at $830K in Q3 2024.
  • 352 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.